EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.8414
March 31, 2026 -0.829
December 31, 2025 -0.8824
September 30, 2025 -0.8988
June 30, 2025 -0.9763
March 31, 2025 -0.6681
December 31, 2024 -0.7083
September 30, 2024 -0.6644
June 30, 2024 -0.6043
March 31, 2024 -0.5929
December 31, 2023 -0.6071
September 30, 2023 -0.5255
June 30, 2023 -0.4734
March 31, 2023 -0.4946
December 31, 2022 -0.7597
September 30, 2022 -0.5457
June 30, 2022 -1.057
March 31, 2022 -0.2122
December 31, 2021 -1.02
Date Value
September 30, 2021 -1.022
June 30, 2021 -0.8394
March 31, 2021 -0.7606
December 31, 2020 -0.7944
September 30, 2020 -0.7912
June 30, 2020 -0.6494
March 31, 2020 -0.5781
December 31, 2019 -0.3884
September 30, 2019 -0.5524
June 30, 2019 -0.4832
March 31, 2019 -0.4202
December 31, 2018 -0.5708
September 30, 2018 -0.4427
June 30, 2018 -1.39
March 31, 2018 -0.3522
December 31, 2017 -0.335
September 30, 2017 -0.2349
June 30, 2017 -0.2329
March 31, 2017 -0.1874

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412
Curis, Inc. -4.017

EPS Diluted (Quarterly) Related Metrics